v3.26.1
Investment in associates (Details Narrative) - USD ($)
12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2024
IfrsStatementLineItems [Line Items]      
Loss of disposal $ 215
Vax Biotech Sdn Bhd [member]      
IfrsStatementLineItems [Line Items]      
Total consideration 0.47    
Loss of disposal $ 677    
Effective equity interest 30.00%  
Cilo Cybin Pharmaceutical [Member]      
IfrsStatementLineItems [Line Items]      
Effective equity interest 9.98%